Establishment of new severity ratings based on analysis of hospital-acquired pneumonia

Respirology

Volumn 14, Issue SUPPL. 2, 2009, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CARBAPENEM;

ASPIRATION; ASPIRATION PNEUMONIA; BODY TEMPERATURE; CELLULAR IMMUNODEFICIENCY; CHRONIC RESPIRATORY TRACT DISEASE; CONSCIOUSNESS LEVEL; DEHYDRATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; GENDER; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HUMORAL IMMUNE DEFICIENCY; KLEBSIELLA; LEUKOCYTE COUNT; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OLIGURIA; PATIENT CODING; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RISK FACTOR; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; VALIDITY; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; FEMALE; HUMANS; JAPAN; MALE; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 72449162260     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01571.x     Document Type: Short Survey

References (11)

1. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 1995 108 (Suppl 1S 16S.
2. American Thoracic Society. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, November 1995. Am. J. Respir. Crit. Care Med. 1996 153 : 1711 25.
3. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005 171 : 388 416.
4. The Committee for the Japanese Respiratory Society Guidelines in the Management of Respiratory Infections. The Japanese Respiratory Society guidelines for the management of hospital-acquired pneumonia in adults. Respirology 2004 9 (Suppl S1 S62.
5. Watanabe A, Yanagihara K, Kohno S et al. Multicenter survey on hospital-acquired pneumonia and the clinical efficacy of first-line antibiotics in Japan. Intern. Med. 2008 47 : 245 54.
6. Saito A, Miki F, Oizumi K et al. Clinical evaluation methods for new antimicrobial agents to treat respiratory infections: Report of the committee for respiratory system, Japan Society of Chemotherapy. J. Infect. Chemother. 1999 5 : 110 23.
7. Lim WS, van der Eerden MM, Laing R et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003 58 : 377 82.
8. The Committee for the Japanese Respiratory Society Guidelines in the Management of Respiratory Infections. The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults. Respirology 2006 11 (Suppl. 3 S1 S133.
9. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997 336 : 243 50.
10. Hedlund J. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short- and long-term prognosis. Scand. J. Infect. Dis. Suppl. 1995 97 : 1 60.
11. Seki M, Watanabe A, Mikasa K et al. Revision of severity rating and classification of hospital-acquired pneumonia in the Japanese respiratory guidelines. Respirology 2008 13 : 880 5.